— Know what they know.
Not Investment Advice

NRXS AMEX

NeurAxis, Inc.
1W: -6.0% 1M: +19.5% 3M: -0.7% YTD: +59.4% 1Y: +128.6% 3Y: +74.7%
$7.11
-0.06 (-0.84%)
 
Weekly Expected Move ±13.7%
$5 $6 $7 $8 $9
AMEX · Healthcare · Biotechnology · Tech Score Strong Buy · Power 68 · $88.7M mcap · 9M float · 1.19% daily turnover · Short 51% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
43.2 / 100
NoneWeakNarrowWide
Primary source: Switching Costs  ·  ROIC: 464.1%
Cost Advantage
50
Intangibles
38
Switching Cost
55
Network Effect
39
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. NRXS shows a Weak competitive edge (43.2/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Switching Costs. ROIC of 464.1% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$8
Avg Target
$8
High
Based on 1 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 1Hold: 0Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$8.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2025-12-22 Craig-Hallum — $7 $8 +1 +136.0% $3.39
2025-06-16 Craig-Hallum Chase Knickerbocker Initiated $7 — +177.8% $2.52

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

D+
Oct 02, 2026
DCF
1
ROE
1
ROA
1
D/E
2
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. NRXS receives an overall rating of D+. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (2/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-10-01 C- D+
2026-05-04 D+ C-
2026-04-01 C- D+
2026-03-19 D+ C-
2026-03-02 C- D+
2026-02-23 D+ C-
2026-01-14 C- D+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 44 Grade D
Profitability
20
Balance Sheet
0
Earnings Quality
34
Growth
63
Value
27
Momentum
59
Safety
100
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. NRXS scores highest in Safety (100/100) and lowest in Balance Sheet (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
5.33
Safe Zone
Piotroski F-Score
6/9
✗ ✗ ✓ ✓ ✓ ✓ ✗ ✓ ✓
Beneish M-Score
-2.21
Unlikely Manipulator
Ohlson O-Score
-1.46
Bankruptcy prob: 18.8%
Moderate
Credit Rating
BBB+
Score: 64.7/100
Trend: Improving
Earnings Quality
—
OCF/NI: 0.71x
Accruals: -26.3%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. NRXS scores 5.33, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. NRXS scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. NRXS's score of -2.21 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. NRXS's implied 18.8% bankruptcy probability is elevated and warrants attention to the balance sheet. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. NRXS receives an estimated rating of BBB+ (score: 64.7/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-9.23x
PEG
-0.30x
P/S
16.69x
P/B
12.79x
P/FCF
-15.73x
P/OCF
—
EV/EBITDA
-10.74x
EV/Revenue
15.15x
EV/EBIT
-10.63x
EV/FCF
-14.30x
Earnings Yield
-8.88%
FCF Yield
-6.36%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. NRXS currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.025
NI / EBT
×
Interest Burden
1.014
EBT / EBIT
×
EBIT Margin
-1.425
EBIT / Rev
×
Asset Turnover
0.622
Rev / Assets
×
Equity Multiplier
1.555
Assets / Equity
=
ROE
-143.2%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. NRXS's ROE of -143.2% is driven by Asset Turnover (0.622), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.02 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 791 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$7.11
Median 1Y
$4.99
5th Pctile
$1.18
95th Pctile
$21.30
Ann. Volatility
90.3%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Brian Carrico
Chief Executive Officer
$345,102 $388,841 $936,439
Timothy Henrichs Financial
ancial Officer
$327,336 $327,922 $817,345
Dr. Adrian Miranda
Chief Medical Officer
$300,000 $171,900 $570,969
Dr. Thomas Carrico
Chief Regulatory Officer
$300,000 $166,308 $566,883

CEO Pay Ratio

2:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $936,439
Avg Employee Cost (SGA/emp): $430,944
Employees: 24

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
24
+14.3% YoY
Revenue / Employee
$148,720
Rev: $3,569,282
Profit / Employee
$-325,023
NI: $-7,800,555
SGA / Employee
$430,944
Avg labor cost proxy
R&D / Employee
$20,567
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 8.1% 9.9% 5.0% 3.6% 8.5% -24.8% 5.7% 14.3% -30.7% -2.9% -2.4% -1.4% -1.43%
ROA -7.0% -27.4% -17.0% -7.2% -10.2% -3.1% -4.2% -1.5% -2.2% -1.4% -1.2% -92.1% -92.13%
ROIC 1.5% 2.9% 3.4% 3.6% 3.7% 4.9% 4.4% 4.5% 3.7% 5.4% 5.9% 4.6% 4.64%
ROCE 7.0% 9.1% 5.1% 3.5% 7.7% -3.4% -8.8% -1.5% -2.8% -2.1% -1.2% -1.1% -1.10%
Gross Margin 85.9% 86.4% 88.4% 88.0% 85.4% 86.2% 84.4% 83.6% 83.3% 85.4% 86.4% 85.9% 85.87%
Operating Margin -6.3% -3.1% -2.8% -3.6% -2.5% -1.9% -2.6% -1.9% -2.6% -1.8% -1.1% -1.1% -1.10%
Net Margin -18.1% -10.0% -3.3% -4.8% -2.6% -1.9% -2.5% -1.9% -2.6% -1.8% -1.1% -1.2% -1.18%
EBITDA Margin -15.0% -9.9% -3.2% -4.5% -2.5% -1.9% -2.5% -1.9% -2.6% -1.7% -1.1% -1.1% -1.06%
FCF Margin -5.9% -5.4% -4.1% -3.7% -2.9% -2.3% -2.2% -1.9% -1.9% -1.8% -1.4% -1.1% -1.06%
OCF Margin -5.9% -5.4% -4.1% -3.7% -2.8% -2.3% -2.2% -1.9% -1.9% -1.8% -1.4% -1.1% -1.06%
ROA 3Y Avg snapshot only -3.00%
ROIC Economic snapshot only -87.85%
Cash ROA snapshot only -56.23%
NOPAT Margin snapshot only -1.14%
Pretax Margin snapshot only -1.44%
R&D / Revenue snapshot only 14.08%
SGA / Revenue snapshot only 2.16%
SBC / Revenue snapshot only 21.19%
Valuation
Metric Trend Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -2.72 -1.21 -1.27 -1.01 -1.72 -1.97 -1.91 -2.87 -4.04 -5.29 -11.12 -11.26 -9.234
P/S Ratio 49.10 16.66 12.34 8.49 8.47 6.05 5.47 6.41 9.05 11.55 18.92 16.67 16.688
P/B Ratio -22.09 -11.98 -6.42 -3.66 -11.60 7.86 62.08 4.85 13.32 12.13 14.10 13.15 12.795
P/FCF -8.32 -3.08 -3.00 -2.28 -2.97 -2.65 -2.51 -3.30 -4.84 -6.38 -13.34 -15.73 -15.728
P/OCF — — — — — — — — — — — — —
EV/EBITDA -3.20 -1.36 -1.52 -1.31 -1.79 -1.65 -1.78 -2.15 -3.56 -4.79 -10.44 -10.74 -10.739
EV/Revenue 48.09 16.81 13.35 9.96 8.56 4.85 4.92 4.70 7.89 10.28 17.35 15.15 15.153
EV/EBIT -3.19 -1.36 -1.52 -1.30 -1.78 -1.64 -1.77 -2.14 -3.54 -4.75 -10.34 -10.63 -10.635
EV/FCF -8.15 -3.10 -3.24 -2.68 -3.00 -2.13 -2.25 -2.42 -4.22 -5.68 -12.23 -14.30 -14.300
Earnings Yield -36.8% -82.9% -78.6% -98.6% -58.2% -50.7% -52.3% -34.8% -24.8% -18.9% -9.0% -8.9% -8.88%
FCF Yield -12.0% -32.5% -33.3% -43.8% -33.7% -37.7% -39.9% -30.3% -20.6% -15.7% -7.5% -6.4% -6.36%
Price/Tangible Book snapshot only 13.679
EV/Gross Profit snapshot only 17.710
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 0.43 0.13 0.11 0.28 0.24 1.75 1.21 2.82 1.58 2.05 2.89 3.04 3.040
Quick Ratio 0.41 0.12 0.10 0.27 0.23 1.74 1.19 2.76 1.55 1.96 2.81 2.95 2.951
Debt/Equity -0.26 -0.16 -0.55 -0.97 -0.27 0.23 1.50 0.11 0.21 0.12 0.06 0.04 0.041
Net Debt/Equity — — — — — -1.56 -6.25 -1.30 -1.71 -1.34 -1.17 -1.19 -1.194
Debt/Assets 0.23 0.44 1.85 1.94 0.42 0.10 0.13 0.07 0.08 0.07 0.04 0.03 0.028
Debt/EBITDA -0.04 -0.02 -0.12 -0.30 -0.04 -0.06 -0.05 -0.07 -0.06 -0.05 -0.05 -0.04 -0.037
Net Debt/EBITDA 0.07 -0.01 -0.11 -0.19 -0.02 0.41 0.20 0.79 0.52 0.59 0.95 1.07 1.072
Interest Coverage -5.02 -8.57 -9.67 -10.51 -36.73 -26.41 -31.98 -57.01 -156.98 -104.46 -157.77 -145.93 -145.933
Equity Multiplier -1.16 -0.36 -0.30 -0.50 -0.64 2.30 11.72 1.67 2.53 1.88 1.52 1.48 1.484
Cash Ratio snapshot only 2.688
Debt Service Coverage snapshot only -144.522
Cash to Debt snapshot only 29.787
FCF to Debt snapshot only -20.162
Defensive Interval snapshot only 261.3 days
Efficiency & Turnover
Metric Trend Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.39 1.98 1.75 0.86 2.06 1.02 1.48 0.66 0.97 0.64 0.73 0.62 0.622
Inventory Turnover 1.95 6.58 10.63 6.75 11.16 10.70 14.41 5.61 7.94 3.73 4.66 3.76 3.757
Receivables Turnover 3.61 13.79 18.29 15.41 26.56 16.90 17.56 23.35 41.74 16.21 13.62 18.94 18.937
Payables Turnover 0.12 0.12 0.17 0.26 0.42 0.39 0.47 0.62 0.57 1.53 1.53 1.22 1.222
DSO 101 26 20 24 14 22 21 16 9 23 27 19 19.3 days
DIO 187 55 34 54 33 34 25 65 46 98 78 97 97.2 days
DPO 3074 3148 2103 1416 878 937 779 592 641 239 239 299 298.6 days
Cash Conversion Cycle -2785 -3066 -2049 -1339 -831 -882 -733 -511 -586 -118 -134 -182 -182.2 days
Fixed Asset Turnover snapshot only 8.612
Operating Cycle snapshot only 116.4 days
Cash Velocity snapshot only 0.639
Capital Intensity snapshot only 1.880
Growth (YoY)
Metric Trend Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue — — — — 4.1% 1.7% 77.3% 41.9% 36.9% 32.9% 45.9% 65.2% 65.22%
Net Income — — — — -40.4% 40.9% 47.7% 62.2% 37.7% 5.4% 13.3% -9.7% -9.73%
EPS — — — — -24.1% 46.2% 54.1% 69.3% 56.0% 27.9% 40.9% 22.9% 22.86%
FCF — — — — -1.5% -12.1% 6.0% 25.9% 10.4% -5.5% 5.1% 9.9% 9.89%
EBITDA — — — — -63.5% 36.6% 44.1% 59.4% 36.6% 3.0% 12.3% -7.0% -6.96%
Op. Income — — — — -1.4% -54.1% -17.6% 17.9% -3.6% -9.4% 4.5% -7.7% -7.73%
OCF Growth snapshot only 9.66%
Asset Growth snapshot only 41.03%
Equity Growth snapshot only 58.35%
Debt Growth snapshot only -41.75%
Shares Change snapshot only 42.24%
Growth Quality
Metric Trend Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability — — — — — — — — 0.96 0.97 1.00 0.95 0.955
Earnings Stability — — — — — — — — 0.05 0.80 0.84 0.70 0.703
Margin Stability — — — — — — — — 0.98 0.98 0.99 0.99 0.985
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence — — — — — — — — 0.85 0.98 0.95 0.96 0.961
Earnings Smoothness — — — — — — — — — — — — —
ROE Trend — — — — — — — — — — — — —
Gross Margin Trend — — — — — — — — -0.02 -0.02 -0.01 -0.00 -0.005
FCF Margin Trend — — — — — — — — 2.51 2.04 1.73 1.77 1.772
Sustainable Growth Rate — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.33 0.39 0.42 0.44 0.58 0.74 0.76 0.87 0.83 0.82 0.83 0.71 0.714
FCF/OCF 1.00 1.00 1.00 1.01 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.002
FCF/Net Income snapshot only 0.716
CapEx/Revenue 0.6% 1.9% 2.0% 1.9% 1.8% 1.0% 1.1% 0.9% 0.8% 0.9% 0.3% 0.2% 0.23%
CapEx/Depreciation snapshot only 0.166
Accruals Ratio -4.70 -16.67 -9.81 -4.02 -4.32 -0.81 -1.02 -0.20 -0.37 -0.25 -0.21 -0.26 -0.263
Sloan Accruals snapshot only 0.231
Cash Flow Adequacy snapshot only -461.002
Dividends & Buybacks
Metric Trend Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — 0 0
Chowder Number — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 0.0% -3.7% -3.0% -3.2% -3.0% 0.0% 0.0% 0.0% 0.0% -6.8% -7.8% -13.4% -13.44%
Total Shareholder Return 0.0% -3.7% -3.0% -3.2% -3.0% 0.0% 0.0% 0.0% 0.0% -6.8% -7.8% -13.4% -13.44%
DuPont Factors
Metric Trend Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.02 1.025
Interest Burden (EBT/EBIT) 1.20 1.12 1.10 1.10 1.03 1.04 1.03 1.02 1.01 1.01 1.01 1.01 1.014
EBIT Margin -15.06 -12.37 -8.79 -7.64 -4.80 -2.96 -2.78 -2.19 -2.23 -2.16 -1.68 -1.42 -1.425
Asset Turnover 0.39 1.98 1.75 0.86 2.06 1.02 1.48 0.66 0.97 0.64 0.73 0.62 0.622
Equity Multiplier -1.16 -0.36 -0.30 -0.50 -0.83 7.93 -1.36 -9.67 14.09 2.04 1.96 1.55 1.555
Per Share
Metric Trend Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-1.40 $-2.21 $-2.45 $-2.74 $-1.73 $-1.19 $-1.13 $-0.84 $-0.76 $-0.86 $-0.67 $-0.65 $-0.65
Book Value/Share $-0.17 $-0.22 $-0.49 $-0.76 $-0.26 $0.30 $0.03 $0.50 $0.23 $0.37 $0.52 $0.56 $0.56
Tangible Book/Share $-0.19 $-0.24 $-0.50 $-0.77 $-0.27 $0.28 $0.02 $0.49 $0.20 $0.34 $0.50 $0.53 $0.53
Revenue/Share $0.08 $0.16 $0.25 $0.33 $0.35 $0.39 $0.39 $0.38 $0.34 $0.39 $0.39 $0.44 $0.44
FCF/Share $-0.46 $-0.87 $-1.04 $-1.22 $-1.00 $-0.89 $-0.86 $-0.73 $-0.64 $-0.71 $-0.55 $-0.46 $-0.46
OCF/Share $-0.46 $-0.86 $-1.03 $-1.21 $-1.00 $-0.88 $-0.85 $-0.73 $-0.63 $-0.71 $-0.55 $-0.46 $-0.46
Cash/Share $0.12 $0.01 $0.01 $0.26 $0.04 $0.53 $0.27 $0.70 $0.44 $0.55 $0.65 $0.69 $0.69
EBITDA/Share $-1.16 $-1.98 $-2.22 $-2.50 $-1.68 $-1.14 $-1.09 $-0.82 $-0.75 $-0.84 $-0.65 $-0.62 $-0.62
Debt/Share $0.05 $0.04 $0.27 $0.74 $0.07 $0.07 $0.05 $0.06 $0.05 $0.05 $0.03 $0.02 $0.02
Net Debt/Share $-0.08 $0.02 $0.25 $0.48 $0.03 $-0.47 $-0.22 $-0.65 $-0.39 $-0.50 $-0.61 $-0.66 $-0.66
Academic Models
Metric Trend Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — 5.334
Altman Z-Prime snapshot only 4.861
Piotroski F-Score 2 2 2 2 2 4 4 4 4 5 5 6 6
Beneish M-Score — — — — -23.67 -2.98 -4.40 -3.57 -2.53 -3.01 -2.69 -2.21 -2.214
Ohlson O-Score snapshot only -1.462
ROIC (Greenblatt) snapshot only -1.09%
Net-Net WC snapshot only $0.51
Credit
Metric Trend Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BBB+
Credit Score 12.74 12.73 12.84 12.75 12.88 27.54 20.84 32.39 27.59 30.04 64.55 64.66 64.662
Credit Grade snapshot only 8
Credit Trend snapshot only 32.277
Implied Spread (bps) snapshot only 225.000
Industry Credit Rank snapshot only 62
Sector Credit Rank snapshot only 58

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms